A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if the drug motexafin gadolinium will be an
effective treatment for patients who have relapsed or refractory multiple myeloma.